Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Prostate Specific Antigen (PSA) Test Market In The Coming Years?
The market size for the prostate specific antigen (psa) test has experienced swift expansion in the past years. It’s projected to rise from $4.15 billion in 2024 to $4.65 billion in 2025, showcasing a compound annual growth rate (CAGR) of 11.9%. Factors contributing to this growth during the historic period include augmented awareness, an aging population, advancements in medical and pharmaceutical fields, and clinical recommendations.
The market size for the prostate specific antigen (psa) test is predicted to experience a swift upsurge in the coming years. The projected growth is to reach $7.27 billion by 2029, with a compound annual growth rate (CAGR) of 11.8%. The anticipated growth during this forecast period is due to improvements in aspects like test precision, the approach of personalized medicine, and the increasing elderly population worldwide. The forecast period will also observe major trends such as a shift towards a combination of biomarkers, technological advancements, point-of-care testing, incorporation of digital health, and an emphasis on early diagnosis and prevention.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp
Which Growth Drivers Are Shaping The Prostate Specific Antigen (PSA) Test Market Outlook?
The surging incidence of prostate cancer is anticipated to stimulate the expansion of the prostate-specific antigen (PSA) test market. Prostate cancer, a malady that originates in the prostate gland, a crucial part of both the male and female reproductive systems, is rising steadily. A frequent way of screening for this form of cancer in men is through the prostate-specific antigen (PSA) test, which gauges the PSA levels in the blood, aiding in early detection and evaluation of risk. For example, the American Society of Clinical Oncology (ASCO), a professional oncology organization based in the US, reported in March 2023 that around 288,300 men in the US were diagnosed with prostate cancer, and roughly 34,700 individuals succumbed to the disease in the same year. Consequently, the growth of the prostate-specific antigen (PSA) test market is being fuelled by the escalating prevalence of prostate cancer.
What Is The Segment Breakdown Of The Prostate Specific Antigen (PSA) Test Market?
The prostate specific antigen (psa) testmarket covered in this report is segmented –
1) By Type: Clinical Laboratory Improvement Amendments (CLIA); Enzyme-Linked Immunosorbent Assay (ELISA); Fluorescence Immunoassay (FIA); Other Types
2) By Application: Screening; Post-Treatment Monitoring; Other Applications
3) By End User: Hospitals; Diagnostic Centers; Research Institutes; Other End Users
Subsegments:
1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests; Non-CLIA Tests
2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits; Competitive ELISA Kits
3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA; Laboratory-Based FIA
4) By Other Types: Chemiluminescent Immunoassay (CLIA); Radioimmunoassay (RIA)
How Are Global Trends Impacting The Development Of The Prostate Specific Antigen (PSA) Test Market?
The rise in technological innovations is a dominant trend within the prostate-specific antigen (PSA) test market. Key players in this market are creating cutting-edge screening tools to maintain their market standing. For instance, LynxDx Inc., a diagnostics firm based in the US, unveiled the MyProstateScore 2.0 in February 2023. This is a non-invasive urine prostate cancer testing tool that leverages a mix of 18 biomarkers, including the unique gene fusion T2:ERG, to deliver a custom risk evaluation for each patient. This screening tool also provides highly precise, stratified risk assessment results that help inform clinical decisions for patients showing elevated PSA levels or abnormal digital rectal exam (DRE) outcomes. Furthermore, this test could enhance prostate cancer screening and care.
Who Are The Major Stakeholders Operating In The Prostate Specific Antigen (PSA) Test Market?
Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Prostate Specific Antigen (PSA) Test Market?
North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp
Browse Through More Reports Similar to the Global Prostate Specific Antigen (PSA) Test Market 2025, By The Business Research Company
Prostate Cancer Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Test And Measurement Equipment Global Market Report 2025
Testosterone Replacement Therapy Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model